Skip to content
Back to RCUS

Arcus Biosciences, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
33
Purchases
0
Sales
33
Purchase value
$0.00
Sale value
$9.09M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Alexander AzoyChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Aug 24, 2026Period of report Aug 21, 20260001771961-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 21, 2026
Common StockF1F22,827$30.00$84.81K39,581Direct
Filing footnotes · 3
  1. F1The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. F2Includes the unvested portion of the Reporting Person's RSU grants.
  3. F3The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Jul 13, 2026Period of report Jul 9, 20260001422996-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 10, 2026
Common StockF1F319,799$28.608$566.41K822,508IndirectBy Trust
SaleJul 10, 2026
Common StockF1F4268$29.397$7.88K822,240IndirectBy Trust
SaleJul 9, 2026
Common StockF1F248,502$30.053$1.46M842,307IndirectBy Trust
Filing footnotes · 5
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $29.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. F5Includes the unvested portion of the Reporting Person's RSU grants.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Jun 24, 2026Period of report Jun 22, 20260001610717-26-000294
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 24, 2026
Common StockF1F56,431$29.6595$190.74K890,809IndirectBy Trust
SaleJun 23, 2026
Common StockF1F314,067$27.6875$389.48K898,937IndirectBy Trust
SaleJun 23, 2026
Common StockF1F41,697$28.0612$47.62K897,240IndirectBy Trust
SaleJun 22, 2026
Common StockF1F29,236$27.0313$249.66K913,004IndirectBy Trust
Filing footnotes · 7
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0050 to $28.1550, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. F5The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.8050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. F6Includes the unvested portion of the Reporting Person's RSU grants.
  7. F7Includes 1,279 shares purchased on May 31, 2026 through the Company's Employee Stock Purchase Plan.
Open on SEC EDGAR
Alexander AzoyChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Jun 1, 2026Period of report Jun 1, 20260001771961-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F2F3F42,562$25.7704$66.02K39,581Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. F2Consists of 2,562 shares purchased on 5/29/2026 through the Company's Employee Stock Purchase Plan.
  3. F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $25.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4Includes the unvested portion of the Reporting Person's RSU grants.
Open on SEC EDGAR
II Robert C. GoeltzChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 12, 2026Period of report May 11, 20260001653881-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Common StockF1F27,763$25.63$198.97K84,161Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. F2Includes the unvested portion of the reporting person's RSU grants.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Jan 7, 2026Period of report Jan 5, 20260001422996-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 5, 2026
Common StockF1F229,670$21.34$633.16K924,393IndirectBy Trust
SaleJan 5, 2026
Common StockF1F32,053$22.34$45.86K922,340IndirectBy Trust
SaleJan 5, 2026
Common StockF1100$23.20$2.32K922,240IndirectBy Trust
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.975 to $21.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.04 to $22.985, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4Includes the unvested portion of the reporting person's RSU grants.
Open on SEC EDGAR
II Robert C. GoeltzChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 2, 2026Period of report Dec 31, 20250001610717-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 31, 2025
Common StockF16,552$23.38$153.19K67,924Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Open on SEC EDGAR
Alexander AzoyChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001771961-25-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 18, 2025
Common StockF5F6F34,343$22.2458$96.61K18,531Direct
SaleDec 17, 2025
Common StockF1F4F32,113$22.1595$46.82K22,874Direct
SaleDec 16, 2025
Common StockF1F2F32,376$21.8843$52.00K24,987Direct
Filing footnotes · 6
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes the unvested portion of the reporting person's RSU grants.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. F5The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
  6. F6The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.90 to $22.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Richard MarkusChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250002056093-25-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F4F34,494$22.1595$99.58K65,647Direct
SaleDec 16, 2025
Common StockF1F2F35,052$21.8843$110.56K70,141Direct
Filing footnotes · 4
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes the unvested portion of the reporting person's RSU grants.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Carolyn C. TangGeneral Counsel
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001836662-25-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F5F46,810$22.1595$150.91K124,734Direct
SaleDec 16, 2025
Common StockF1F2F3F47,658$21.8843$167.59K131,544Direct
Filing footnotes · 5
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes 1 share purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan.
  4. F4Includes the unvested portion of the reporting person's RSU grants.
  5. F5The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Jennifer JarrettChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001671311-25-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F4F39,983$22.1595$221.22K193,024Direct
SaleDec 16, 2025
Common StockF1F2F311,225$21.8843$245.65K203,007Direct
Filing footnotes · 4
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes the unvested portion of the reporting person's RSU grants.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
II Robert C. GoeltzChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001653881-25-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F4F35,960$22.1595$132.07K74,476Direct
SaleDec 16, 2025
Common StockF1F2F36,702$21.8843$146.67K80,436Direct
Filing footnotes · 4
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes the unvested portion of the reporting person's RSU grants.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001422996-25-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F4F39,983$22.1595$221.22K346,012Direct
SaleDec 16, 2025
Common StockF1F2F311,225$21.8843$245.65K355,995Direct
Filing footnotes · 4
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes the unvested portion of the reporting person's RSU grants.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Terry J RosenDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001182473-25-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F5F3F425,744$22.1595$570.47K2,194,809Direct
SaleDec 16, 2025
Common StockF1F2F3F428,947$21.8843$633.48K2,220,553Direct
Filing footnotes · 5
  1. F1Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes 236 shares purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan.
  4. F4Includes the unvested portion of the reporting person's RSU grants.
  5. F5The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Dec 5, 2025Period of report Dec 4, 20250001422996-25-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 4, 2025
Common StockF1F282,997$24.7069$2.05M954,063IndirectBy Trust
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Alexander AzoyChief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Dec 1, 2025Period of report Nov 26, 20250001771961-25-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 26, 2025
Common StockF11,900$26.00$49.40K27,363Direct
Filing footnotes · 2
  1. F1The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. F2The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.
Open on SEC EDGAR
II Robert C. GoeltzChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 26, 2025Period of report Nov 26, 20250001653881-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 26, 2025
Common StockF15,000$25.00$125.00K87,138Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Open on SEC EDGAR
Juan C. JaenPresident
4Rule 10b5-1 plan disclosed
Filed Nov 19, 2025Period of report Nov 17, 20250001422996-25-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 18, 2025
Common StockF1F45,050$19.75$99.74K1,037,060IndirectBy Trust
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.
  2. F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.